IMMUCELL CORP /DE/ Quarterly Deferred Tax Assets, Gross in USD from Q4 2013 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Immucell Corp /De/ quarterly Deferred Tax Assets, Gross history and growth rate from Q4 2013 to Q4 2022.
  • Immucell Corp /De/ Deferred Tax Assets, Gross for the quarter ending December 31, 2022 was $665K, a 752% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $665K +$587K +752% Dec 31, 2022 10-K 2023-03-29
Q4 2021 $78.1K -$365K -82.4% Dec 31, 2021 10-K 2023-03-29
Q4 2020 $443K Dec 31, 2020 10-K 2022-03-30
Q4 2017 $473K +$272K +135% Dec 31, 2017 10-K 2018-03-29
Q4 2016 $201K -$251K -55.5% Dec 31, 2016 10-K 2018-03-29
Q4 2015 $452K -$809K -64.1% Dec 31, 2015 10-K 2017-03-30
Q4 2014 $1.26M +$90.9K +7.77% Dec 31, 2014 10-K 2016-03-25
Q4 2013 $1.17M Dec 31, 2013 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.